Impact Biomedical (IBO) Accounts Payables (2022 - 2026)
Impact Biomedical (IBO) posted Accounts Payables of $374000.0 for Q1 2026, up 7.78% on a QoQ basis from $347000.0 in Q4 2025, and down 39.19% year-over-year from $615000.0 in Q1 2025.
Impact Biomedical (IBO) Accounts Payables (2022 - 2026) Analysis & Trends
Impact Biomedical's Accounts Payables history runs 5 years deep, the most recent figure standing at $374000.0 for Q1 2026.
- Quarterly Accounts Payables fell 39.19% year-over-year to $374000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $374000.0 (down 39.19% YoY) and the FY2025 annual result came in at $347000.0, down 51.33% from the prior year.
- Accounts Payables was $374000.0 for Q1 2026 at Impact Biomedical, up from $347000.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $1.0 million in Q1 2024 and bottomed at $301000.0 in Q2 2023.
- A 5-year average of $641307.7 and a median of $576000.0 in 2025 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables surged 227.57% — and 2025, when it slumped 51.33%.
- Impact Biomedical's Accounts Payables stood at $539000.0 in 2022, then jumped by 54.36% to $832000.0 in 2023, then slipped by 14.3% to $713000.0 in 2024, then sank by 51.33% to $347000.0 in 2025, then climbed by 7.78% to $374000.0 in 2026.
- Business Quant data shows IBO's Accounts Payables at $374000.0 in Q1 2026, $347000.0 in Q4 2025, and $576000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | 374,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 374,000.00 |
| Dec 31, 2025 | 347,000.00 |
| Sep 30, 2025 | 576,000.00 |
| Jun 30, 2025 | 554,000.00 |
| Mar 31, 2025 | 615,000.00 |
| Dec 31, 2024 | 713,000.00 |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 986,000.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 832,000.00 |
| Sep 30, 2023 | 476,000.00 |
| Jun 30, 2023 | 301,000.00 |
| Dec 31, 2022 | 539,000.00 |